These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15371919)

  • 21. Effect of H. pylori on COX-2 expression in gastric remnant after distal gastrectomy.
    Fukuhara K; Osugi H; Takada N; Takemura M; Lee S; Morimura K; Taguchi S; Kaneko M; Tanaka Y; Fujiwara Y; Nishizawa S; Fukushima S; Kinoshita H
    Hepatogastroenterology; 2004; 51(59):1515-8. PubMed ID: 15362790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cyclooxygenase-2 inhibition on human Helicobacter pylori gastritis: mechanisms underlying gastrointestinal safety and implications for cancer chemoprevention.
    Scheiman JM; Greenson JK; Lee J; Cryer B
    Aliment Pharmacol Ther; 2003 Jun; 17(12):1535-43. PubMed ID: 12823157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histopathology and expression of Ki-67 and cyclooxygenase-2 in childhood Helicobacter pylori gastritis.
    Kim KM; Oh YL; Ko JS; Choe YH; Seo JK
    J Gastroenterol; 2004; 39(3):231-7. PubMed ID: 15064999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric MALT-lymphoma, gastrin and cyclooxygenases.
    Konturek PC; Konturek SJ; Pierzchalski P; Starzyńska T; Marlicz K; Hartwich A; Zuchowicz M; Darasz Z; Papiez D; Hahn EG
    Acta Gastroenterol Belg; 2002; 65(1):17-23. PubMed ID: 12014312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease.
    Meining A; Kiel G; Stolte M
    Aliment Pharmacol Ther; 1998 Aug; 12(8):735-40. PubMed ID: 9726386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased COX-2, but not COX-1, mRNA expression in Helicobacter pylori gastritis.
    Zarrilli R; Tuccillo C; Santangelo M; Nardone G; Romano M
    Am J Gastroenterol; 1999 Nov; 94(11):3376-8. PubMed ID: 10566756
    [No Abstract]   [Full Text] [Related]  

  • 27. Resolution of gastritis induced by Helicobacter pylori 4-5 weeks after successful eradication of infection using a triple therapy regimen of pantoprazole, amoxycillin and clarithromycin for one week.
    Abdul Aal GM; Dajani AI; Nounou M; Awad S; Abdul Rasheed Z; Gautam S; Ukabam S; Nayal S
    Digestion; 1999; 60(3):286-97. PubMed ID: 10343145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication.
    Zhou L; Sung JJ; Lin S; Jin Z; Ding S; Huang X; Xia Z; Guo H; Liu J; Chao W
    Chin Med J (Engl); 2003 Jan; 116(1):11-4. PubMed ID: 12667379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastric corpus IL-8 concentration and neutrophil infiltration in duodenal ulcer patients.
    Uemura N; Oomoto Y; Mukai T; Okamoto S; Yamaguchi S; Mashiba H; Taniyama K; Sasaki N; Sumii K; Haruma K; Kajiyama G
    Aliment Pharmacol Ther; 1997 Aug; 11(4):793-800. PubMed ID: 9305491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A follow-up study on the effect of Helicobacter pylori eradication on the severity of gastric histology.
    Salih BA; Abasiyanik MF; Saribasak H; Huten O; Sander E
    Dig Dis Sci; 2005 Aug; 50(8):1517-22. PubMed ID: 16110845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole.
    Berstad AE; Hatlebakk JG; Maartmann-Moe H; Berstad A; Brandtzaeg P
    Gut; 1997 Dec; 41(6):740-7. PubMed ID: 9462205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients.
    Pilotto A; Franceschi M; Leandro G; Bozzola L; Fortunato A; Rassu M; Meli S; Soffiati G; Scagnelli M; Di Mario F; Valerio G
    J Gastroenterol Hepatol; 1999 May; 14(5):468-75. PubMed ID: 10355512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-dependent eradication of Helicobacter pylori with dual therapy.
    Treiber G; Ammon S; Klotz U
    Aliment Pharmacol Ther; 1997 Aug; 11(4):711-8. PubMed ID: 9305480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.
    Hirschowitz BI; Haber MM
    Aliment Pharmacol Ther; 2001 Jan; 15(1):87-103. PubMed ID: 11136282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori eradication decreases the expression of glycosylphosphatidylinositol-anchored complement regulators, decay-accelerating factor and homologous restriction factor 20, in human gastric epithelium.
    Joh T; Sasaki M; Kataoka H; Tanida S; Itoh K; Kondo Y; Ogasawara N; Oshima T; Okada N; Ohara H; Sano H; Nakao H; Sobue S; Itoh M
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1344-51. PubMed ID: 16105119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Reduction in Gastric Atrophy after
    Niikura R; Hayakawa Y; Hirata Y; Ogura K; Fujishiro M; Yamada A; Ushiku T; Konishi M; Fukayama M; Koike K
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of bacterial eradication on the cell proliferation and p53 protein accumulation in Helicobacter pylori-associated gastritis.
    Hsu PI; Lai KH; Chien EJ; Lin CK; Lo GH; Jou HS; Cheng JS; Chan HH; Hsu JH; Ger LP; Hsu PN; Tseng HH
    Anticancer Res; 2000; 20(2B):1221-8. PubMed ID: 10810425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of neutrophil infiltration in the corpus after failure of Helicobacter pylori eradication.
    Suzuki M; Mori M; Miyayama A; Iwai N; Tsunematsu N; Oonuki M; Suzuki H; Hibi T; Ishii H
    J Clin Gastroenterol; 1997; 25 Suppl 1():S222-8. PubMed ID: 9479652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
    Liu D; He Q; Liu C
    J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localisation of cyclooxygenase 1 and cyclooxygenase 2 in Helicobacter pylori related gastritis and gastric ulcer tissues in humans.
    Tatsuguchi A; Sakamoto C; Wada K; Akamatsu T; Tsukui T; Miyake K; Futagami S; Kishida T; Fukuda Y; Yamanaka N; Kobayashi M
    Gut; 2000 Jun; 46(6):782-9. PubMed ID: 10807888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.